MedPath

Registry Study for Radiation Therapy Outcomes

Recruiting
Conditions
Neoplasms
Registration Number
NCT01255748
Lead Sponsor
Proton Collaborative Group
Brief Summary

The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40000
Inclusion Criteria
  • Planned treatment with radiation therapy
  • Ability to understand and sign IRB approved consent
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Define outcomes for patients treated at participating institutionsPRN
Secondary Outcome Measures
NameTimeMethod
Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and proceduresAnnually PRN
Improve patient care by an adequate understanding of the results and patient population at participating institutionsReviewed Annually PRN

Trial Locations

Locations (23)

Mayo Clinic

🇺🇸

Scottsdale, Arizona, United States

California Protons Cancer Therapy Center

🇺🇸

San Diego, California, United States

South Florida Proton Therapy Institute

🇺🇸

Delray Beach, Florida, United States

Ackerman Cancer Center

🇺🇸

Jacksonville, Florida, United States

Miami Cancer Institute

🇺🇸

Miami, Florida, United States

Orlando Health Cancer Institute

🇺🇸

Orlando, Florida, United States

Emory Proton Therapy Center

🇺🇸

Atlanta, Georgia, United States

Northwestern Medicine Chicago Proton Center

🇺🇸

Warrenville, Illinois, United States

University of Kansas Proton Therapy Center

🇺🇸

Kansas City, Kansas, United States

Kansas City Proton Institute

🇺🇸

Overland Park, Kansas, United States

Scroll for more (13 remaining)
Mayo Clinic
🇺🇸Scottsdale, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.